filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - priprave za zdravljenje ran in razjed - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
koŽni vbodni (prick) test - betula verrucose - birch (breza)
iris d.o.o. - raztopina za kožni vbodni test - alergijski testi
episalvan
amryt ag - betulae cortex - wounds and injuries; wound healing - priprave za zdravljenje ran in razjed - zdravljenje delnih ran z debelino pri odraslih. glej poglavja 4. 4 in 5. 1 v podatkih o izdelku glede na vrsto preučenih ran.
itulazax 12 sq-bet peroralni liofilizat
alergenski izvleček cvetnega prahu navadne breze, standardizirani - peroralni liofilizat - alergenski izvleček cvetnega prahu navadne breze, standardizirani 12 sq-bet / 1 liofilizat - drevesni cvetni prah
itulazax 12 sq-bet peroralni liofilizat
alergenski izvleček cvetnega prahu navadne breze, standardizirani - peroralni liofilizat - alergenski izvleček cvetnega prahu navadne breze, standardizirani 12 sq-bet / 1 liofilizat - drevesni cvetni prah
mircera
roche registration gmbh - metoksi polietilen glikol-epoetin beta - anemia; kidney failure, chronic - antianemični preparati - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.
jaypirca
eli lilly nederland b.v. - pirtobrutinib - limfom, mantle cell - proteinska kinaza inhibitorji - treatment of mantle cell lymphoma (mcl).
circlet 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem
n. v. organon, oss - etinilestradiol; etonogestrel - vaginalni dostavni sistem - etinilestradiol 0,015 mg / 24 ura etonogestrel0,12 mg / 24 ura; etonogestrel 0,12 mg / 24 ura - vaginalni obroček s progestogenom in estrogenom
circlet 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem
n. v. organon, oss - etinilestradiol; etonogestrel - vaginalni dostavni sistem - etinilestradiol 0,015 mg / 24 ura etonogestrel0,12 mg / 24 ura; etonogestrel 0,12 mg / 24 ura - vaginalni obroček s progestogenom in estrogenom
thyrogen
sanofi b.v. - tirotropin alfa - Širokopasemske neoplazme - spodnjega režnja hipofize hormoni in analogi, hipofize in hypothalamic hormoni in analogi - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.